Challenge #1: An Abundance of Biomarker Data
Today’s guest post is from Reinhard von Roemeling, board certified oncologist and former SVP of global oncology at EMD-Serono/Merck KGaA.
Despite several years of interest, pharmaceutical companies have yet to immerse themselves in the world of EHR data integration. However, as the EHR market matures globally, the move from double data entry to EHR integration is rapidly approaching.
What role should EHR play in the future of clinical trials? My colleagues at Medidata and I spend a lot of time talking about EHR, clinical trials, and where we are headed. This post kicks off a series on EHR and clinical trials. We’re starting off with the basics. What is EHR? Because the answer is a little more complicated than it seems. And if you want to hear more, check out our EHR breakout session at Medidata NEXT Basel on March 7.